Patents by Inventor Patrick Cottler

Patrick Cottler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11623029
    Abstract: Biologically acceptable surgical barrier materials are comprised of a polyelectrolytic complex of chitosan and sodium alginate. The chitosan is deacetylated in an amount between about 40 to about 60% and has a molecular weight (Mw) between 50,000 and 375,000 g/mol. The barrier materials may be formed by mixing a two-component material system whereby one component comprises the chitosan and a second component comprises the sodium alginate and directing such a mixture (e.g., via air-assisted spray nozzle) toward a surgical site in need of the material. A polyelectrolytic complex of the chitosan and sodium alginate will thereby form in situ. Suitable ionic cross-linkers may be provided in the individual components, e.g., calcium chloride with the chitosan component and sodium tripolyphosphate with the sodium alginate component.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: April 11, 2023
    Assignee: LUNA LABS USA, LLC
    Inventors: Lauren Anne Costella, Michael J. Danilich, Christopher K. Tison, Patrick Cottler
  • Publication number: 20200101203
    Abstract: Biologically acceptable surgical barrier materials are comprised of a polyelectrolytic complex of chitosan and sodium alginate. The chitosan is deacetylated in an amount between about 40 to about 60% and has a molecular weight (Mw) between 50,000 and 375,000 g/mol. The barrier materials may be formed by mixing a two-component material system whereby one component comprises the chitosan and a second component comprises the sodium alginate and directing such a mixture (e.g., via air-assisted spray nozzle) toward a surgical site in need of the material. A polyelectrolytic complex of the chitosan and sodium alginate will thereby form in situ. Suitable ionic cross-linkers may be provided in the individual components, e.g., calcium chloride with the chitosan component and sodium tripolyphosphate with the sodium alginate component.
    Type: Application
    Filed: March 28, 2018
    Publication date: April 2, 2020
    Inventors: Lauren Anne COSTELLA, Michael J. DANILICH, Christopher K. TISON, Patrick COTTLER
  • Publication number: 20050033197
    Abstract: An apparatus and method capable of percutaneous or direct removal of blood and other body fluids, or infusion of medicinal, therapeutic, bioactive mixtures. The fluid transport apparatus includes a fluid collection chamber (20); cutting devices (50) attached to the collection chamber to penetrate the skin of the patient (2); and a vacuum supply (61) in communication with the fluid collection chamber (20); whereby the vacuum supply (61) providing a vacuum pressure to remove congested fluid from the patient through the cutting devices (50) into the collection chamber (20). Further, the apparatus may provides conduits (28) disposed on the collection chamber (20) that are juxtaposed or concentric with the cutting devices (50), whereby vacuum pressure to removes the congested fluid from the patient (2) through the conduit (28) into the collection chamber (20).
    Type: Application
    Filed: December 6, 2002
    Publication date: February 10, 2005
    Inventor: Patrick Cottler